Enterobacteriaceae
| | | | |
Age < 1 year
|
4.6 (2–11.1)
|
0.0004
|
4.4 (1.9–10.9)
|
0.0008
|
Stage C disease
|
3.7 (1.6–8.6)
|
0.002
|
3.6 (1.5–8.6)
|
0.005
|
Female
|
0.5 (0.23–1.19)
|
0.13
| | |
CDC Immunological Class 2 or 3
|
2 (0.7–6.9)
|
0.23
| | |
Weight for age-Z-score <-2
|
1.6 (0.7–3.5)
|
0.27
| | |
No prior TMP-SMX at baseline
|
0.3 (0.03–1.3)
|
0.22
| | |
Present and/or previous hospitalization
|
1.1 (0.4–3.7)
|
0.9
| | |
S. aureus
|
1 (0.3–3.8)
|
1
| | |
Age < 1 year
|
1.2(0.6–2.4)
|
0.6
| | |
Stage C
|
0.1 (0.6–2.9)
|
0.4
| | |
Weight for age-Z-score <-2
|
2 (1–3.9)
|
0.051
|
1.7 (0.8–3.5)
|
0.11
|
CDC Immunological Class 2 or 3
|
3.7 (1.4–12.9)
|
0.007
|
3.4 (1.3–11.8)
|
0.029
|
Female
|
1.2 (0.63–2.4)
|
0.54
| | |
No prior TMP-SMX at baseline
|
0.97 (0.42–2.1)
|
0.94
| | |
Present and/or previous hospitalization
|
2.04 (0.8–6.3)
|
0.14
| | |
S. pneumoniae
| | | | |
Age < 1 year
|
0.53 (0.2–1.1)
|
0.09
| | |
Stage C
|
0.51 (0.2–1.6)
|
0.13
| | |
Weight for age-Z-score <-2
|
0.71 (0.4–1.4)
|
0.31
| | |
CDC Immunological Class 2 or 3
|
0.8 (0.4–1.6)
|
0.5
| | |
Female
|
0.97 (0.5–1.9)
|
0.92
| | |
No prior TMP-SMX at baseline
|
1.4 (0.4–5.3)
|
0.67
| | |
Present and/or previous hospitalization
|
0.64 (0.29–1.46)
|
0.28
| | |
Gram-negative respiratory organisms
| | | | |
Age < 1 year
|
0.53 (0.2–0.98)
|
0.055
|
0.59 (0.24–1.33)
|
0.22
|
Stage C
|
0.8 (0.3–1.7)
|
0.51
| | |
Weight for age-Z-score <-2
|
0.46 (0–0.9)
|
0.029
|
0.55 (0.25–1.2)
|
0.14
|
CDC Immunological Class 2 or 3
|
0.32 (0.16–0.66)
|
0.002
|
0.33 (0.15–0.71)
|
0.005
|
Female
|
1.4 (0.75–2.8)
|
0.28
| | |
No prior TMP-SMX at baseline
|
5.1 (1.4–22.1)
|
0.058
|
0.33 (0.09–0.94)
|
0.057
|
Present and/or previous hospitalization
|
0.5 (0.23–1.12)
|
0.094
|
0.63 (0.27–1.54)
|
0.3
|